Evidence map›Paper›PMID 19339410›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2009

In-center nocturnal hemodialysis: another option in the management of chronic kidney disease.

Ann Bugeja, Niki Dacouris, Alison Thomas, Rosa Marticorena, Philip McFarlane, Sandra Donnelly, Marc Goldstein

Open access · bronzeAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2012
    Pooled it
  4. Efficacy and safety ofContemporary clinical trials communications · 2023
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
    Article
  16. Observational
  17. Article
  18. Nocturnal intermittent hemodialysis.Pediatric nephrology (Berlin, Germany) · 2015
    Review
  19. Review
  20. Cost analysis of in-centre nocturnal compared with conventional hemodialysis.Canadian journal of kidney health and disease · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ann BugejaDepartment of Medicine, Ottawa Hospital, Division of Nephrology, Kidney Research Centre, University of Ottawa, Ottawa, Canada. marc.goldstein@utoronto.ca
Niki Dacouris
Alison Thomas
Rosa Marticorena
Philip McFarlane
Sandra Donnelly
Marc Goldstein
University of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSome patients are not optimally treated by conventional in-center hemodialysis (HD) and are unable to perform home HD. We examined the effect of in-center thrice-weekly nocturnal HD (INHD) on patient outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients who were not optimally treated on conventional HD were offered INHD. Thirty-nine patients' laboratory data and medication use were analyzed for the 12 mo before and after conversion to INHD until September 1, 2007. Quality of life on conventional HD and INHD was compared.

resultsAfter conversion to INHD, median values for phosphorus decreased from 5.9 to 3.7 mg/dl (P < 0.01), alkaline phosphatase level increased from 84 to 161 U/L (P < 0.01), and percentage reduction in urea increased from 74 to 89% (P < 0.01). The mean number of antihypertensive drugs prescribed declined from 2.0 to 1.5 (P < 0.05) during the course of INHD, and the mean daily dosage of phosphate binders declined from 6.2 to 4.9 at study end (P < 0.05). There was a significant reduction in erythropoietin-stimulating agent use of 1992 U/wk (P < 0.01). There was no significant change in median hemoglobin, iron saturation, corrected calcium, or parathyroid hormone levels. Overall, quality of life, sleep, intradialytic cramps, appetite, and energy level all improved significantly on INHD.

conclusionsINHD offers an effective form of HD for long-term dialysis patients who are unable to perform home HD.

Indexed as

Circadian RhythmHemodialysis Units, HospitalAdultAlkaline PhosphataseAntihypertensive AgentsAttitude of Health PersonnelBiomarkersCalciumChronic DiseaseFeasibility StudiesFemaleHealth Knowledge, Attitudes, PracticeHematinicsHemoglobinsHumansIronAlkaline PhosphataseAntihypertensive AgentsBiomarkersCalciumHematinicsHemoglobinsIronParathyroid HormonePhosphorus

Identifiers

PMID19339410
PMCPMC2666425
OpenAlexW2123520141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.